peyton
eggleston
md
baltimor
md
injammatori
process
upper
airway
may
alter
respons
lower
airway
exampl
bronchial
hyperrespons
may
seen
patient
allerg
rhiniti
could
repres
coexist
unrecogn
asthma
also
suggest
igedepend
inflamm
may
occur
lower
airway
increas
bronchial
hyperrespons
without
time
precipit
obviou
obstruct
clearli
allerg
rhiniti
risk
factor
asthma
second
exampl
interact
upper
airway
inflamm
bronchial
hyperreact
report
viral
upper
respiratori
tract
infect
may
caus
otherwis
healthi
person
respond
abnorm
inhal
histamin
irrit
sever
month
infect
virus
usual
precipit
attack
patient
asthma
alreadi
hyperrespons
airway
exampl
suggest
inflammatori
process
occur
total
primarili
upper
airway
may
particip
pathogenesi
lower
respiratori
tract
hyperrespons
asthma
allergi
clin
immljnol
bronchial
hyperreact
defin
abnorm
respons
airway
express
increas
air
flow
obstruct
exposur
varieti
physic
chemic
pharmacolog
bronchoprovoc
agent
equal
well
express
prompt
revers
obstruct
beta
adrenerg
agonist
bronchodil
hyperrespons
almost
alway
present
asthma
sometim
consid
pathognomon
may
also
seen
cystic
fibrosi
chronic
bronchiti
lung
diseas
bronchial
hyperreact
usual
thought
abnorm
lower
respiratori
tract
recent
describ
two
disord
lower
respiratori
tract
usual
normal
patient
allerg
rhiniti
risk
asthma
subsequ
frequent
exhibit
increas
bronchial
hyperrespons
acut
viral
upper
respiratori
tract
infect
may
induc
bronchial
respons
de
novo
induct
hyperrespons
airway
infect
suggest
mechan
may
explain
frequent
associ
upper
respiratori
tract
infect
wheez
episod
patient
asthma
also
healthi
person
develop
persist
bronchial
hyperrespons
mechan
underli
hyperrespons
airway
known
suggest
abnorm
may
exist
mucos
permeabl
autonom
control
bronchial
smooth
muscl
smooth
muscl
hypothes
presum
abnorm
lower
respiratori
tract
offer
explan
abnorm
respons
seen
diseas
appar
limit
upper
respiratori
tract
access
molecul
lumen
respiratori
tract
submucos
structur
limit
normal
state
mainten
tight
junction
epitheli
cell
junction
may
disrupt
exposur
igemedi
howev
abnorm
bronchoconstrict
also
occur
histamin
given
parenter
patient
sole
mechan
calib
lower
airway
balanc
autonom
control
vagal
effer
nerv
decreas
airway
calib
affer
input
reflex
may
origin
irrit
receptor
either
lower
upper
tract
major
balanc
factor
sympathet
tone
decreas
beta
adrenerg
respons
shown
asthma
h
chronic
bronchiti
viral
upper
respiratori
tract
abnorm
bronchial
smooth
muscl
either
hypertrophi
increas
mass
abnorm
respons
characterist
propos
mechan
hyperract
usual
method
estim
bronchial
reactiv
use
bronchoprovoc
agent
two
common
challeng
exercis
inhal
methacholin
histamin
techniqu
exercis
challeng
describ
detail
gener
minut
strenuou
exercis
requir
caus
signific
reproduc
airflow
chang
test
appli
almost
exclus
children
young
adult
isocapn
hyperventil
ventilatori
chang
associ
exercis
reproduc
voluntarili
becom
wide
use
substitut
inhal
challeng
usual
conduct
use
histamin
methacholin
determin
baselin
control
respons
inhal
salin
solut
agonist
inhal
begin
low
concentr
ml
progress
stepwis
increas
dose
usual
doubl
step
pulmonari
function
test
measur
step
test
stop
signific
respons
occur
result
express
dose
concentr
caus
pulmonari
function
test
chang
given
amount
control
valu
usual
chang
fev
peak
expiratori
flow
rate
dose
call
pd
fev
express
breath
unit
breath
unit
one
inhal
mgi
ml
pc
fev
concentr
milligram
per
millilit
caus
chang
fev
distil
water
inhal
increasingli
longer
time
also
use
demonstr
result
test
correl
reason
well
one
anoth
thu
appear
measur
abnorm
allerg
rhiniti
said
risk
facror
develop
asthma
examin
adult
asthma
coexist
rhiniti
clear
rhiniti
preced
asthma
studi
broder
et
al
entir
popul
small
town
michigan
would
appear
rhiniti
preced
asthma
often
first
studi
person
identifi
allerg
rhiniti
restudi
year
later
person
asthma
nevertheless
rate
substanti
higher
new
case
asthma
identifi
person
without
allerg
rhiniti
period
allerg
rhiniti
childhood
may
associ
develop
asthma
frequent
anderson
et
al
examin
children
enrol
nation
child
develop
studi
england
scotland
wale
repres
cohort
observ
sinc
birth
singl
week
iit
march
age
year
complet
questionnair
interview
examin
school
physician
total
wheez
childhood
point
preval
ii
year
respect
allerg
rhiniti
sneez
attack
age
year
time
like
wheez
sometim
childhood
allerg
rhiniti
may
risk
factor
develop
asthma
suggest
frequent
associ
airway
hyperreact
comparison
respons
histamin
bronchoprovoc
healthi
volunt
patient
allerg
rhiniti
asthma
illustr
fig
twentynin
percent
reaction
bronchial
challeng
test
demonstr
current
past
histori
asthma
ix
howev
person
allerg
rhiniti
clearli
less
respons
asthma
even
allerg
sensit
assess
skin
test
leukocyt
histamin
releas
studi
compar
signific
associ
allerg
rhiniti
asthma
abnorm
airway
respons
regard
pathogenesi
asthma
unknown
first
approach
understand
associ
worth
consid
link
allergi
abnorm
airway
reactiv
base
report
cluster
abnorm
methacholin
respons
among
atop
famili
investig
suggest
possibl
genet
basi
anoth
possibl
hyperrespons
aris
atop
person
acquir
abnorm
perhap
consequ
inflammatori
chang
lower
respiratori
tract
cockcroft
et
shown
control
intrapulmonari
deposit
allergen
laboratori
environment
allergen
produc
transient
increas
histamin
methacholin
respons
allerg
patient
develop
latephas
asthmat
reaction
chang
order
magnitud
found
normal
person
viral
respiratori
tract
infect
exposur
although
caus
increas
reactiv
unknown
possibl
mechan
suggest
demonstr
mucos
permeabl
may
substanti
increas
antigen
challeng
sensit
final
piec
evid
link
allerg
inflamm
demonstr
patient
asthma
allerg
hous
dust
mite
isol
antigen
bronchial
reactiv
decreas
significantli
sever
month
increas
bronchial
hyperrespons
allerg
rhiniti
relat
allergeninduc
inflammatori
chang
alter
mucos
permeabl
lower
airway
may
relat
natur
environment
exposur
aeroallergen
result
igemedi
reaction
upper
respiratori
tract
lower
respiratori
tract
effect
lower
airway
subclin
suffici
caus
perceiv
symptom
evid
circumstanti
nonetheless
compel
patient
hay
fever
asthma
compar
insignific
differ
allergen
sensit
term
skin
sensit
leukocyt
histamin
number
investig
shown
patient
allerg
rhiniti
never
asthmat
symptom
demonstr
physiolog
alter
typic
acut
asthma
inhal
appropri
allergen
patient
asthma
remain
slightli
hyperrespons
hay
fever
especi
fev
respons
nevertheless
differ
small
consider
overlap
group
patient
respond
inhal
allergen
laboratori
natur
environment
exposur
entir
clear
like
explan
amount
allergen
encount
natur
condit
far
less
use
laboratori
experi
abil
sustain
clinic
respons
condit
lower
level
allergen
exposur
depend
preexist
abnorm
airway
reactiv
henc
patient
mark
increas
airway
respons
asthma
exampl
may
sustain
substanti
airway
respons
mild
allerg
reaction
patient
modest
increas
respons
allerg
rhiniti
experi
littl
clinic
effect
despit
absenc
clinic
percept
airway
respons
patient
seem
plausibl
allerg
stimul
capabl
caus
inflammatori
chang
well
subclin
airflow
obstruct
although
direct
evid
support
report
subtl
abnorm
lower
airway
function
patient
hay
fever
interv
environment
allergen
exposur
symptomat
rhiniti
classifi
patient
clearcut
asthma
clearcut
rhiniti
often
difficult
may
deni
symptom
wheez
chest
tight
admit
cough
particular
pollen
season
histori
wheez
predict
airway
reactiv
seem
reason
view
patient
symptom
clearcut
asthma
exclus
symptom
rhiniti
particular
pollen
season
exposur
anim
dander
repres
either
end
respect
spectrum
allerg
respiratori
bronchial
respons
thu
although
common
underli
abnorm
hay
fever
asthma
still
known
whether
exist
activ
allerg
airway
diseas
express
allerg
rhiniti
somehow
modifi
lower
respiratori
tract
lead
progress
hyperrespons
eventu
clinic
asthma
base
studi
show
allergen
exposur
result
increas
airway
respons
tempt
specul
exist
data
emphas
import
obtain
care
clinic
histori
regard
chest
symptom
patient
allerg
rhiniti
begin
bronchodil
therapi
symptom
report
acut
viral
upper
respiratori
tract
infect
clearli
associ
exacerb
asthma
children
associ
acut
bacteri
infect
upper
respiratori
tract
exacerb
asthma
effect
chronic
upper
respiratori
tract
infect
chronic
sinus
discuss
elsewher
symposium
inform
studi
children
conduct
mcintosh
et
minor
et
studi
adult
chronic
exacerb
could
associ
acut
viral
ill
avail
experi
asthma
summar
tabl
prospect
studi
patient
asthma
halperin
et
al
j
evalu
volunt
wellcharacter
asthma
experiment
infect
one
two
rhinoviru
serotyp
four
volunt
show
appreci
chang
fev
infect
five
distinguish
volunt
signific
persist
increas
bronchial
hyperrespons
consist
lower
incid
wheez
viral
infect
seen
adult
suggest
may
agerel
differ
host
respons
viral
infect
suggest
support
exist
bronchiol
croup
children
two
syndrom
first
seen
respiratori
syn
virus
associ
lower
tract
ill
tabl
ii
usual
found
acut
cold
gener
popul
respiratori
syncyti
viru
coronaviru
recov
primarili
small
children
asthma
mqeczsrna
pneumonia
influenza
found
chiefli
adult
agent
vari
greatli
pathobiolog
characterist
almost
certain
sever
mechan
involv
induc
asthma
attack
influenza
parainfluenza
adenoviru
exampl
caus
widespread
sever
epitheli
damag
upper
lower
tract
signific
inflammatori
respons
pneumonia
rhinoviru
hand
produc
trivial
epitheli
damag
upper
respiratori
tract
colon
lower
tract
infect
respiratori
syncyti
viru
parainfluenza
viru
respiratori
virus
caus
immedi
hypersensit
effect
human
airway
found
induc
ige
antibodi
secret
associ
wheez
associ
wheez
episod
asthma
clearli
associ
acut
infect
develop
de
novo
bronchial
reactiv
normal
person
much
less
clear
parker
et
al
first
describ
abnorm
methacholin
respons
acut
upper
respiratori
tract
infect
howev
viral
origin
establish
case
inasmuch
five
patient
retain
abnorm
respons
methacholin
clear
whether
normal
infect
whether
appar
cold
simpli
worsen
underli
hyperrespons
empey
et
demonstr
bronchial
respons
return
normal
long
month
fail
identifi
specif
viral
caus
third
studi
show
abnorm
bronchial
respons
exercis
cold
air
acut
upper
respiratori
tract
infect
three
differ
agent
isolatedmycoplasma
rhinoviru
respiratori
syncyti
virusbut
differ
three
agent
discuss
import
specifi
viral
origin
develop
bronchial
hyperrespons
describ
previous
patholog
process
infect
differ
common
cold
virus
differ
wide
major
impact
mechan
bronchial
reactiv
develop
also
whether
develop
exampl
two
studi
document
influenza
infect
demonstr
increas
respons
patient
two
studi
rhinoviru
infect
demonstr
chang
respons
third
demonstr
twofold
increas
histamin
reactiv
differ
influenza
infect
rhinoviru
support
hypothesi
mucos
disrupt
inflamm
necessari
bronchial
hyperreact
time
question
de
novo
gener
hyperrespons
viral
infect
remain
unansw
last
studi
rhinoviru
provid
data
regard
patient
statu
infect
summari
bronchial
hyperrespons
seen
ill
involv
upper
respiratori
tract
allerg
rhiniti
appear
coexist
constitut
risk
factor
asthma
acut
respiratori
tract
infect
asthmat
attack
may
occur
coincid
viral
infect
infect
specif
virus
may
caus
normal
person
develop
bronchial
hyperrespons
bronchial
hyperrespons
may
take
month
clear
may
predispos
condit
longterm
sequela
